Revenue
Roche Pharmaceuticals Revenue
+1.63%
+17.54%
Diagnostics Revenue
+1.3%
+13.73%
Chugai Revenue
+0.41%
+4.17%
Revenue by Geography
Rest of Europe Revenue
+3.05%
+35%
Germany Revenue
+0.66%
+6.8%
Japan Revenue
+0.64%
+6.56%
United States Revenue
+1.87%
+20.35%
Latin America Revenue
+0.45%
+4.62%
Rest of North America Revenue
-2.33%
-20.99%
EBIT
Corporate Operating Profit
+1.91%
+20.83%
Roche Pharmaceuticals Operating Profit
-0.51%
-4.98%
Diagnostics Operating Profit
-0.03%
-0.27%
Chugai Operating Profit
-0.68%
-6.56%
Capital Expenditures
Chugai Capital Expenditures
+3.13%
+36.11%
Corporate Capital Expenditures
+0.44%
+4.52%
Roche Pharmaceuticals Capital Expenditures
-0.28%
-2.78%
Diagnostics Capital Expenditures
+0.02%
+0.2%
